AlpinumisoflavoneCAS# 34086-50-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 34086-50-5 | SDF | Download SDF |
PubChem ID | 5490139 | Appearance | Powder |
Formula | C20H16O5 | M.Wt | 336.3 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5-hydroxy-7-(4-hydroxyphenyl)-2,2-dimethylpyrano[3,2-g]chromen-6-one | ||
SMILES | CC1(C=CC2=C(O1)C=C3C(=C2O)C(=O)C(=CO3)C4=CC=C(C=C4)O)C | ||
Standard InChIKey | RQAMSFTXEFSBPK-UHFFFAOYSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Alpinumisoflavone has atheroprotective effects, may result from their ability to upregulate mechanisms promoting HDL-cholesterol and bile acid formation. 2. Alpinumisoflavone is endowed with estrogenic properties accounting, at least in part, for E. lysistemon effects. 3. Alpinumisoflavone induces cell death, may be via repressing both the ERK/MAPK and NF-κB pathways. 4. Alpinumisoflavone, abyssione-V 4'-O-methyl ether, 6,8-diprenylgenistein, and burttinone are active against both Gram-negative and Gram-positive bacteria, the minimum inhibitory concentration values obtained (MIC) ranged from 3.9 ug/mL to 125 ug/mL. |
Targets | MEK | ERK | MAPK | NO | NF-kB | LDL | Antifection |
Alpinumisoflavone Dilution Calculator
Alpinumisoflavone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.9735 mL | 14.8677 mL | 29.7354 mL | 59.4707 mL | 74.3384 mL |
5 mM | 0.5947 mL | 2.9735 mL | 5.9471 mL | 11.8941 mL | 14.8677 mL |
10 mM | 0.2974 mL | 1.4868 mL | 2.9735 mL | 5.9471 mL | 7.4338 mL |
50 mM | 0.0595 mL | 0.2974 mL | 0.5947 mL | 1.1894 mL | 1.4868 mL |
100 mM | 0.0297 mL | 0.1487 mL | 0.2974 mL | 0.5947 mL | 0.7434 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- (20S)-Protopanaxatriol
Catalog No.:BCN2705
CAS No.:34080-08-5
- Z-Pro-NH2
Catalog No.:BCC2753
CAS No.:34079-31-7
- 2-2'-(Hydroxytetracosanoylamino)-octadecane-1,3,4-triol tetraacetate
Catalog No.:BCN1454
CAS No.:340702-68-3
- 1,3-Bis(4,5-dihydro-2-oxazolyl)benzene
Catalog No.:BCC8417
CAS No.:34052-90-9
- Diclofensine hydrochloride
Catalog No.:BCC5541
CAS No.:34041-84-4
- SMIFH2
Catalog No.:BCC6162
CAS No.:340316-62-3
- Auranofin
Catalog No.:BCC7952
CAS No.:34031-32-8
- H-D-Phe-OtBu.HCl
Catalog No.:BCC3014
CAS No.:3403-25-6
- 1-BCP
Catalog No.:BCC6909
CAS No.:34023-62-6
- Vinorine
Catalog No.:BCN4649
CAS No.:34020-07-0
- Z-Ala-OSu
Catalog No.:BCC3057
CAS No.:3401-36-3
- 7-Oxodehydroabietinol
Catalog No.:BCN5265
CAS No.:33980-71-1
- 7-O-Methylbiochanin A
Catalog No.:BCN8212
CAS No.:34086-51-6
- Glycyrrhetic acid 3-O-mono-beta-D-glucuronide
Catalog No.:BCN1453
CAS No.:34096-83-8
- Araloside V
Catalog No.:BCN2466
CAS No.:340963-86-2
- Fmoc-D-Asp-OtBu
Catalog No.:BCC3470
CAS No.:34098-70-7
- Araloside VII
Catalog No.:BCN8129
CAS No.:340982-22-1
- Nucleozin
Catalog No.:BCC1811
CAS No.:341001-38-5
- Sunitinib malate
Catalog No.:BCC3664
CAS No.:341031-54-7
- (+)-Sophoranol
Catalog No.:BCN3743
CAS No.:3411-37-8
- Paludosine
Catalog No.:BCN2010
CAS No.:34137-24-1
- Celastrol
Catalog No.:BCN5986
CAS No.:34157-83-0
- Catalponol
Catalog No.:BCN5267
CAS No.:34168-56-4
- Pterosin Z
Catalog No.:BCN5268
CAS No.:34169-69-2
Alpinumisoflavone induces apoptosis and suppresses extracellular signal-regulated kinases/mitogen activated protein kinase and nuclear factor-kappaB pathways in lung tumor cells.[Pubmed:21415528]
Biol Pharm Bull. 2011;34(2):203-8.
The extracellular signal-regulated kinases/mitogen activated protein kinase (ERK/MAPK) and nuclear factor-kappaB (NF-kappaB) pathways are critical for cell survival and proliferation. Alpinumisoflavone (AIF), isolated from the African medicinal plant Erythrina lysistemon, is a member of the isoflavone group. In this report, we demonstrated that AIF treatment induces cell death of human lung tumor cells. Incubation of lung tumor cells with AIF increased the sub-G1 population and caspase 3/7 activity, suggesting that the cell death is caused by apoptosis. To identify the signaling pathway involved in the tumor cell death, we examined the modulation of transcriptional activity using various reporter constructs and found that AIF significantly deregulated both the ERK/MAPK and NF-kappaB pathways. Western blot analysis with antibodies to MAP/ERK kinase (MEK) and ERK showed that AIF dephosphorylates both MEK and ERK. Alpinumisoflavone also repressed lipopolysaccharide (LPS)-induced nitric oxide (NO) production in RAW264.7 cells by inhibiting NF-kappaB-dependent transcription. Therefore, the cell death induced by AIF may be via repressing both the ERK/MAPK and NF-kappaB pathways.
Effects of alpinumisoflavone and abyssinone V-4'-methyl ether derived from Erythrina lysistemon (Fabaceae) on the genital tract of ovariectomized female Wistar rat.[Pubmed:22183714]
Phytother Res. 2012 Jul;26(7):1029-36.
Erythrina lysistemon is an African medicinal plant used as a palliative for problems in women. The crude extract of this plant was shown to exhibit estrogenic effects on the female rat reproductive tract and on cell cuture. Using classic chromatographic methods, two compounds have been isolated as major constituents of this extract: Alpinumisoflavone (1) and abyssinone V-4'-methyl ether (2). To determine whether both compounds are actives principles accounting for E. lysistemon effects, we applied the classic 3-day uterotrophic assay. We also carried out a ligand binding assay to determine whether the observed effects are estrogen receptor (ER) mediated. This study showed that whereas compound 1 displayed a fourfold preference for ERalpha, compound 2 bound ERalpha and ERbeta with a same affinity. The in vivo study showed that compound 1 increased the uterine wet weight by 182.23% (p < 0.01) and 71.79% (p < 0.05) at doses of 0.1 and 1 mg/kg BW/day respectively. The uterine epithelium thickened dose-dependently. Vaginal epithelial height also increased by 369.97 and 226.76% respectively (p < 0.01). Compound 2 acted only on the vagina and increased vaginal epithelial height by 244.56% (p < 0.01) at 1 mg/kg BW/day. These results suggest that compounds 1 and 2 are endowed with estrogenic properties accounting, at least in part, for E. lysistemon effects.
Alpinumisoflavone.[Pubmed:21202104]
Acta Crystallogr Sect E Struct Rep Online. 2008 Mar 14;64(Pt 4):o713.
The title compound, C(20)H(16)O(5), {systematic name: 5-hydr-oxy-7-(4-hydroxy-phen-yl)-2,2-dimethyl-2H,6H-benzo[1,2-b:5,4-b']dipyran-6- one}, was obtained by demethyl-ation of the biologically active related compound, 4-O-methyl-alpinum-iso-flavone. The mol-ecular structure of the title compound is characterized by a fused tricyclic system that contains an approximately planar benzopyrone ring fragment. The six membered pyran ring adopts a half-chair conformation. Both ring systems show an out-of-plane twist. The dihedral angle between the mean plane of the benzopyrone system and the benzene ring is 54.29 (3) degrees . The mol-ecules are linked by O-Hcdots, three dots, centeredO hydrogen bonds, forming a mol-ecular tape running along the b axis.
Alpinumisoflavone and abyssinone V 4'-methylether derived from Erythrina lysistemon (Fabaceae) promote HDL-cholesterol synthesis and prevent cholesterol gallstone formation in ovariectomized rats.[Pubmed:25683903]
J Pharm Pharmacol. 2015 Jul;67(7):990-6.
OBJECTIVES: Erythrina lysistemon was found to improve lipid profile in ovariectomized rats. Alpinumisoflavone (AIF) and abyssinone V 4'-methylether (AME) derived from this plant induced analogous effects on lipid profile and decreased atherogenic risks. To highlight the molecular mechanism of action of these natural products, we evaluated their effects on the expression of some estrogen-sensitive genes associated with cholesterol synthesis (Esr1 and Apoa1) and cholesterol clearance (Ldlr, Scarb1 and Cyp7a1). METHODS: Ovariectomized rats were subcutaneously treated for three consecutive days with either compound at the daily dose of 0.1, 1 and 10 mg/kg body weight (BW). Animals were sacrificed thereafter and their liver was collected. The mRNA of genes of interest was analysed by quantitative real-time polymerase chain reaction. KEY FINDINGS: Both compounds downregulated the mRNA expression of Esr1, a gene associated with cholesterogenesis and cholesterol gallstone formation. AME leaned the Apoa1/Scarb1 balance in favour of Apoa1, an effect promoting high-density lipoprotein (HDL)-cholesterol formation. It also upregulated the mRNA expression of Ldlr at 1 mg/kg/BW per day (25%) and 10 mg/kg/BW per day (133.17%), an effect favouring the clearance of low-density lipoprotein (LDL)-cholesterol. Both compounds may also promote the conversion of cholesterol into bile acids as they upregulated Cyp7a1 mRNA expression. CONCLUSION: AIF and AME atheroprotective effects may result from their ability to upregulate mechanisms promoting HDL-cholesterol and bile acid formation.
Antibacterial activity of flavonoids from the stem bark of Erythrina caffra thunb.[Pubmed:20623615]
Phytother Res. 2011 Jan;25(1):46-8.
The antibacterial activity of the stem bark of Erythrina caffra Thunb. was investigated against different bacterial strains. The antibacterial activity was determined by a micro broth dilution assay. Antibacterial compounds were isolated and identified using a Bruker Avance III LPO NMR spectrometer. Four known flavonoids, abyssione-V 4'-O-methyl ether, 6,8-diprenylgenistein, Alpinumisoflavone and burttinone, were isolated. All the compounds were active against both Gram-negative and Gram-positive bacteria. The minimum inhibitory concentration values obtained (MIC) ranged from 3.9 mug/mL to 125 mug/mL. This is the first report of antibacterial activity of burttinone and the isolation of these compounds from E. caffra.